Editorial: Recent advances in progestin-primed ovarian stimulation
Príomhchruthaitheoir: | Qiuju Chen |
---|---|
Formáid: | Alt |
Teanga: | English |
Foilsithe / Cruthaithe: |
Frontiers Media S.A.
2022-11-01
|
Sraith: | Frontiers in Endocrinology |
Ábhair: | |
Rochtain ar líne: | https://www.frontiersin.org/articles/10.3389/fendo.2022.1004352/full |
Míreanna comhchosúla
Míreanna comhchosúla
-
Progestin-Primed Ovarian Stimulation versus GnRH Antagonist Protocol for Ovarian Stimulation in IVF: A Prospective Pilot Study
de réir: Tien K. Le, et al.
Foilsithe / Cruthaithe: (2024-03-01) -
Non-inferiority of progestin-primed ovarian stimulation versus GnRH antagonist protocol: A propensity score-weighted analysis
de réir: Le Duc Thang, et al.
Foilsithe / Cruthaithe: (2024-04-01) -
Progestin-Primed Ovarian Stimulation Protocol for Patients With Endometrioma
de réir: Ai-Min Yang, et al.
Foilsithe / Cruthaithe: (2022-04-01) -
Progestin Primed Ovarian Stimulation (PPOS) protocol yields lower euploidy rate in older patients undergoing IVF
de réir: Angel Hsin-Yu Pai, et al.
Foilsithe / Cruthaithe: (2023-08-01) -
Micronized natural progesterone (Seidigestan®) vs GnRH antagonists for preventing the LH surge during controlled ovarian stimulation (PRO_NAT study): study protocol of a randomized clinical trial
de réir: M. Martínez-Moya, et al.
Foilsithe / Cruthaithe: (2024-03-01)